BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 9803483)

  • 21. [Treatment of familial combined hyperlipidemia].
    Bruckert E
    Ann Endocrinol (Paris); 1997; 58(4):297-301. PubMed ID: 9436478
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of spin traps to investigate site-specific formation of free radicals in low-density lipoprotein oxidation.
    Kalyanaraman B; Joseph J; Parthasarathy S
    Biochem Soc Trans; 1993 May; 21(2):318-21. PubMed ID: 8395423
    [No Abstract]   [Full Text] [Related]  

  • 23. Mode of action of fibrates.
    Catapano AL
    Pharmacol Res; 1992 Dec; 26(4):331-40. PubMed ID: 1294939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia.
    Sattar N; Gaw A; Packard CJ; Greer IA
    Br J Obstet Gynaecol; 1996 Jul; 103(7):614-20. PubMed ID: 8688385
    [No Abstract]   [Full Text] [Related]  

  • 25. Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrate.
    Nagyová A; Raslová K; Ginter E
    Physiol Res; 1998; 47(3):185-90. PubMed ID: 9803483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of ciprofibrate in hyperlipoproteinaemias.
    Turpin G; Bruckert E
    Atherosclerosis; 1996 Jul; 124 Suppl():S83-7. PubMed ID: 8831920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy.
    Chapman MJ; Bruckert E
    Atherosclerosis; 1996 Jul; 124 Suppl():S21-8. PubMed ID: 8831912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
    Burkitt MJ
    Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance of the size of low-density-lipoproteins and the modulation of subclasses by fibrates.
    Rizzo M; Berneis K
    Curr Med Res Opin; 2007 May; 23(5):1103-11. PubMed ID: 17519077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of the copper dependent oxidation of low-density lipoprotein.
    Patel RP; Darley-Usmar VM
    Free Radic Res; 1999 Jan; 30(1):1-9. PubMed ID: 10193568
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.